van Assen S - Search Results

1

Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.

Rondaan C, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, van Assen S, Bijl M, Westra J. Rondaan C, et al. Among authors: van assen s, van leer c. Arthritis Rheumatol. 2014 Nov;66(11):3122-8. doi: 10.1002/art.38804. Arthritis Rheumatol. 2014. PMID: 25223407

2

Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.

Rondaan C, van Leer CC, van Assen S, Bootsma H, de Leeuw K, Arends S, Bos NA, Westra J. Rondaan C, et al. Among authors: van leer cc, van assen s. Lupus. 2018 Jul;27(8):1271-1278. doi: 10.1177/0961203318770535. Epub 2018 Apr 18. Lupus. 2018. PMID: 29667858 Free PMC article.

3

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Holvast A, et al. Among authors: van assen s. Arthritis Rheum. 2009 Aug;60(8):2438-47. doi: 10.1002/art.24679. Arthritis Rheum. 2009. PMID: 19644961 Free article.

4

Vaccination of patients with autoimmune inflammatory rheumatic diseases.

Westra J, Rondaan C, van Assen S, Bijl M. Westra J, et al. Among authors: van assen s. Nat Rev Rheumatol. 2015 Mar;11(3):135-45. doi: 10.1038/nrrheum.2014.206. Epub 2014 Dec 9. Nat Rev Rheumatol. 2015. PMID: 25486980 Review.

5

Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.

Rondaan C, de Joode AAE, van Assen S, Bos NA, Westerhuis R, Westra J. Rondaan C, et al. Among authors: van assen s. Antiviral Res. 2018 Oct;158:206-212. doi: 10.1016/j.antiviral.2018.08.006. Epub 2018 Aug 10. Antiviral Res. 2018. PMID: 30102958

6

Immune response to varicella-zoster virus before and after renal transplantation.

Rondaan C, de Joode AAE, Wang L, Siderius M, Raveling-Eelsing E, van Leer-Buter C, van Assen S, Bos NA, Westra J. Rondaan C, et al. Among authors: van assen s. Antiviral Res. 2020 Nov;183:104938. doi: 10.1016/j.antiviral.2020.104938. Epub 2020 Oct 6. Antiviral Res. 2020. PMID: 32979400 Free article.

7

Vaccination of the immune-compromised patients with focus on patients with autoimmune-inflammatory diseases.

Bijl M, Kallenberg CG, van Assen S. Bijl M, et al. Among authors: van assen s. Neth J Med. 2011 Jan;69(1):5-13. Neth J Med. 2011. PMID: 21325695 Free article. Review.

8

Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).

van Assen S, Bijl M. van Assen S, et al. Lupus. 2012 Feb;21(2):162-7. doi: 10.1177/0961203311429555. Lupus. 2012. PMID: 22235048 Review.

9

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.

Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M. Westra J, et al. Among authors: van assen s. Clin Exp Immunol. 2014 Oct;178(1):40-7. doi: 10.1111/cei.12390. Clin Exp Immunol. 2014. PMID: 24889761 Free PMC article.

10

Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis.

Holvast A, de Haan A, van Assen S, Stegeman CA, Huitema MG, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Holvast A, et al. Among authors: van assen s. Ann Rheum Dis. 2010 May;69(5):924-7. doi: 10.1136/ard.2009.112813. Epub 2009 Jul 12. Ann Rheum Dis. 2010. PMID: 19596692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page